Neurocrine Biosciences Inc
$138.40
▼ 0.54
(-0.39%)
Volume: 1,145,466
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
26
- 21d momentum -11.6%
- MA aligned bearish
- RSI 26 oversold
🎯
Pullback
71
- RSI 26 near lows
- Near lower Bollinger band
- -8.3% vs 20MA
💎
Value
58
- -26% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)25.6
MACD-1
MA trendBearish
ATR2.88%
21d mom.-11.6%
63d mom.-17.9%
vs 20MA-8.3%
RVOL(20)0.99×
52w low · 122
52w high · 186
-25.6% from 52-week high
20d support 137
· resistance 160
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$14.1B
PER20.02
PBR3.82
PSR4.19
EPS$6.94
ROE19.1%
ROA13.2%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA16.48
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -5.35% | -11.62% | -17.87% | +4.52% | -5.64% | -1.56% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -11.08%, daily vol 1.45%. Neurocrine Biosciences Inc sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.